合并与不合并髋部骨折的老年人血n-3脂肪酸与骨量及骨髓TRAP-5b的关联
在因骨质疏松性髋部骨折(28例)或骨关节炎(44例)行髋部手术的患者中,血浆n-3脂肪酸水平在髋部骨折组较骨关节炎组低26.2%(P=0.006),校正混杂后每增加1个标准差的血浆n-3脂肪酸,骨质疏松性髋部骨折的多变量校正比值比为0.40(P=0.010)。在所有患者中,血浆n-3脂肪酸较高与腰椎和全股骨骨量较高相关,与骨髓穿刺液中抗酒石酸酸性磷酸酶-5b水平呈负相关,但与骨特异性碱性磷酸酶无关。
要点
- 髋部骨折患者血浆n-3脂肪酸水平较骨关节炎患者低26.2%(P=0.006)。
- 血浆n-3脂肪酸每增加1个标准差,骨质疏松性髋部骨折的多变量校正OR为0.40(P=0.010)。
- 血浆n-3脂肪酸较高与腰椎和全股骨骨量较高相关,与骨髓TRAP-5b呈负相关。
核心结论
- 这些发现提供临床证据表明n-3脂肪酸是潜在的破骨细胞生成抑制剂,有利于人类骨骼健康。
研究设计与样本
- 病例对照和横断面研究,在临床单元进行,采集72例因骨质疏松性髋部骨折(n=28)或骨关节炎(n=44)行髋部手术患者的骨髓液。
- 采用气相色谱/质谱法测定血n-3脂肪酸,采用免疫分析法测定骨髓穿刺液中的骨生化标志物。
主要发现
- 校正混杂因素后,髋部骨折患者血浆n-3脂肪酸水平较骨关节炎患者低26.2%(P=0.006)。
- 血浆n-3脂肪酸每增加1个标准差,与骨质疏松性髋部骨折的多变量校正比值比为0.40(P=0.010)相关。
- 在包括所有患者的多变量分析中,较高的血浆n-3脂肪酸水平与较高的腰椎骨量(β=0.615,P=0.002)和全股骨骨量(β=0.244,P=0.045)相关。
- 血浆n-3脂肪酸水平与骨髓穿刺液中抗酒石酸酸性磷酸酶-5b水平呈负相关(β=-0.633,P=0.023)。
- 血浆n-3脂肪酸水平与骨髓穿刺液中骨特异性碱性磷酸酶水平无显著关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The plasma n-3 fatty acid level was 26.2% lower in patients with osteoporotic hip fracture than in those with osteoarthritis. In all patients, n-3 fatty acid was positively associated with bone mineral density and inversely associated with tartrate-resistant acid phosphatase-5b level in bone marrow aspirates, reflecting the bone microenvironment. INTRODUCTION: Despite the potential beneficial role of n-3 fatty acid (FA) on bone metabolism, the specific mechanisms underlying these effects in humans remain unclear. Here, we assessed whether the plasma n-3 level, as an objective indicator of its status, is associated with osteoporosis-related phenotypes and bone-related markers in human bone marrow (BM) samples. METHODS: This was a case-control and cross-sectional study conducted in a clinical unit. n-3 FA in the blood and bone biochemical markers in the BM aspirates were measured by gas chromatography/mass spectrometry and immunoassay, respectively. BM fluids were collected from 72 patients who underwent hip surgery because of either osteoporotic hip fracture (HF; n = 28) or osteoarthritis (n = 44). RESULTS: After adjusting for confounders, patients with HF had 26.2% lower plasma n-3 levels than those with osteoarthritis (P = 0.006), and each standard deviation increment in plasma n-3 was associated with a multivariate-adjusted odds ratio of 0.40 for osteoporotic HF (P = 0.010). In multivariate analyses including all patients, a higher plasma n-3 level was associated with higher bone mass at the lumbar spine (β = 0.615, P = 0.002) and total femur (β = 0.244, P = 0.045). Interestingly, the plasma n-3 level was inversely associated with the tartrate-resistant acid phosphatase-5b level (β = - 0.633, P = 0.023), but not with the bone-specific alkaline phosphatase level, in BM aspirates. CONCLUSIONS: These findings provide clinical evidence that n-3 FA is a potential inhibitor of osteoclastogenesis that favors human bone health.
引用
- Kim BJ, Yoo HJ, Park SJ, et al. Association of blood n-3 fatty acid with bone mass and bone marrow TRAP-5b in the elderly with and without hip fracture. Osteoporos Int. 2019. PMID: 30719549. doi:10.1007/s00198-019-04881-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。